Medical Outcomes Liaison
MAPS Public Benefit Corporation
Remote · United States
Posted on Wednesday, November 1, 2023
About Lykos Therapeutics
At Lykos Therapeutics, we are committed to making an impact on people’s lives. We envision a world where there are more tools available for the treatment of mental health and where conversations about mental health are destigmatized. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. Our initial focus is developing investigational MDMA-assisted therapy for adults living with PTSD. If approved by the FDA, MDMA-assisted therapy could be a potential new approach to treating PTSD, a condition that hasn’t had a new treatment option in decades.
MDMA-assisted therapy has been designated a Breakthrough Therapy by the FDA and the results of our two pivotal Phase 3 clinical trials were published in Nature Medicine. MDMA-assisted therapy has not been approved by any regulatory agency. The safety and efficacy of MDMA-assisted therapy have not been established for the treatment of PTSD.
Lykos is a public benefit corporation (PBC), with a dual mandate to generate shareholder value and public benefit. As a PBC, we consider the impact of our decisions on society just as we think about financial implications. We balance the interests of our many stakeholders including our employees, healthcare providers, therapists, investors and others. This means that we look through a public benefit lens with all that we do.
Why work for Lykos Therapeutics?
With 30+ years of experience researching psychedelic-assisted therapies, we remain committed to the rigorous pursuit of evidence-based development of novel approaches. We value impact, integrity, care, and openness and hold public benefit at the center of everything we do. We believe in diversity and inclusion of people of all backgrounds, genders, races, ethnicities, sexual orientations, educational backgrounds, arrest or conviction record, military and veteran status, religions, abilities, and perspectives and are committed to building a supportive, equitable, and accessible workplace.
Lykos has a distributed workforce that uses technology and periodic in-person gatherings to stay connected. We look for people who believe in our mission, are comfortable with and skilled at remote work and collaboration, and ready to step into a dynamic and fast-paced work environment.
Medical Outcomes Liaison Executive Summary
The Medical Outcomes Liaison (MOL) is a field-based Medical Affairs professional who serves a key role in engaging with national and regional population-based decision-makers (PBDMs) to strategically support MAPS PBC scientific and business objectives. The MOL is responsible for leveraging their scientific expertise, experience, and knowledge of managed care, health policy, and pharmacoeconomics to engage in scientific and health economics discussions with PBDM audiences including, but not limited to, national and regional payors, pharmacy benefit managers (PBMs), integrated delivery networks (IDNs) and health systems.
- Strategic Vision: The MOL will develop and execute MAPS PBC’s Health Economic Outcomes Research (HEOR) strategy by collaborating with internal Medical Affairs and Market Access partners to ensure strategic alignment and support a PBDM engagement plan that will deliver exceptional customer experiences. They will collaborate with PBDMs to understand their information needs regarding management strategies, scientific priorities, evidence needs, decision-making processes, and clinical perspectives on MAPS PBC products, disease states, and research, and will utilize available resources to meet PBDMs’ needs. The MOL will gather and share customer insights to help inform Medical Affairs, Market Access, and brand strategies.
- Payor Engagement: The MOL is the first-line strategic and tactical Medical Affairs point of contact for national, regional, and governmental PBDMs. They will utilize clinical, value, and outcomes evidence including observational research, comparative effectiveness, and pharmacoeconomic data to partner with PBDMs to address their needs in support of MAPS PBC products and related therapies. Develop and maintain peer-to-peer collaborations and relationships with PBDMs.
- Expertise: The MOL will attend HEOR and Managed Markets conferences to present data, attend relevant scientific sessions and professionally network and build relationships in the HEOR and Managed Markets professional community. They will maintain deep market and customer knowledge in an increasingly complex and dynamic healthcare ecosystem.
- Advanced degree from an accredited institution. PharmD, MD, DO, or PhD preferred.
- 5+ years of experience in a Managed Care/PBM, VA/DoD, CMS, State Medicaid, health care consulting, pharmaceutical industry, or related environment with a track record of success in a compliant and professional manner.
- Excellent knowledge and command of clinical trial design and methodology, observational study designs, epidemiology, biostatistics, value frameworks, and health economic principles.
- Thorough knowledge of FDA guidance on advertising and promotion of prescription drugs and medical devices, safe harbor, scientific exchange, and PhRMA code.
- Ability to interpret scientific data, understand the potential impact of scientific data on clinical approaches and research needs, and communicate scientific data to broad audiences.
- Excellent interpersonal communication skills; superior presentation and public speaking skills; ability to present complex information in an accessible way.
- Strong business acumen with the ability to think strategically about how territory tactics will affect department initiatives and outcomes.
- Experience in CNS, psychiatry, or psychology preferred.
Competitive benefit package includes:
Paid Time Off (PTO)
Medical, dental, vision, and life insurance
Employer funded mental health HRA
Home Office Stipend
We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.